Global Lentiviral Vector (LVV) CDMO Services Market Growth (Status and Outlook) 2022-2028
The global market for Lentiviral Vector (LVV) CDMO Services is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Lentiviral Vector (LVV) CDMO Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Lentiviral Vector (LVV) CDMO Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Lentiviral Vector (LVV) CDMO Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Lentiviral Vector (LVV) CDMO Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Lentiviral Vector (LVV) CDMO Services players cover Thermo Fisher Scientific, GenScript ProBio, Hillgene, Charles River Laboratories and Ubrigene, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Lentiviral Vector (LVV) CDMO Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Lentiviral Vector (LVV) CDMO Services market, with both quantitative and qualitative data, to help readers understand how the Lentiviral Vector (LVV) CDMO Services market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Lentiviral Vector (LVV) CDMO Services market and forecasts the market size by Type (IIT Grade, IND Grade and Clinical Trial Grade), by Application (Biopharmaceutical Company and Academic Scientific Research Institution.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
IIT Grade
IND Grade
Clinical Trial Grade
Commercial Production Grade
Segmentation by application
Biopharmaceutical Company
Academic Scientific Research Institution
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Thermo Fisher Scientific
GenScript ProBio
Hillgene
Charles River Laboratories
Ubrigene
Obio Technology (shanghai)
Genesail Biotech (Shanghai)
Wuxi Apptec
Porton Advanced Solutions
Pharmaron
Asymchem Laboratories (Tianjin)
Merck
VectorBuilder
Yposkesi
Flash Therapeutics
VIVEBiotech
Miltenyi Bioindustry
Genezen
Miltenyi Biotec
Exthera
Catalent
Chapter Introduction
Chapter 1: Scope of Lentiviral Vector (LVV) CDMO Services, Research Methodology, etc.
Chapter 2: Executive Summary, global Lentiviral Vector (LVV) CDMO Services market size and CAGR, Lentiviral Vector (LVV) CDMO Services market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Lentiviral Vector (LVV) CDMO Services revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Lentiviral Vector (LVV) CDMO Services revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Lentiviral Vector (LVV) CDMO Services market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Thermo Fisher Scientific, GenScript ProBio, Hillgene, Charles River Laboratories, Ubrigene, Obio Technology (shanghai), Genesail Biotech (Shanghai), Wuxi Apptec and Porton Advanced Solutions, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lentiviral Vector (LVV) CDMO Services Market Size 2017-2028
2.1.2 Lentiviral Vector (LVV) CDMO Services Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Lentiviral Vector (LVV) CDMO Services Segment by Type
2.2.1 IIT Grade
2.2.2 IND Grade
2.2.3 Clinical Trial Grade
2.2.4 Commercial Production Grade
2.3 Lentiviral Vector (LVV) CDMO Services Market Size by Type
2.3.1 Lentiviral Vector (LVV) CDMO Services Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Type (2017-2022)
2.4 Lentiviral Vector (LVV) CDMO Services Segment by Application
2.4.1 Biopharmaceutical Company
2.4.2 Academic Scientific Research Institution
2.5 Lentiviral Vector (LVV) CDMO Services Market Size by Application
2.5.1 Lentiviral Vector (LVV) CDMO Services Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Application (2017-2022)
3 Lentiviral Vector (LVV) CDMO Services Market Size by Player
3.1 Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Players
3.1.1 Global Lentiviral Vector (LVV) CDMO Services Revenue by Players (2020-2022)
3.1.2 Global Lentiviral Vector (LVV) CDMO Services Revenue Market Share by Players (2020-2022)
3.2 Global Lentiviral Vector (LVV) CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lentiviral Vector (LVV) CDMO Services by Regions
4.1 Lentiviral Vector (LVV) CDMO Services Market Size by Regions (2017-2022)
4.2 Americas Lentiviral Vector (LVV) CDMO Services Market Size Growth (2017-2022)
4.3 APAC Lentiviral Vector (LVV) CDMO Services Market Size Growth (2017-2022)
4.4 Europe Lentiviral Vector (LVV) CDMO Services Market Size Growth (2017-2022)
4.5 Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size Growth (2017-2022)
5 Americas
5.1 Americas Lentiviral Vector (LVV) CDMO Services Market Size by Country (2017-2022)
5.2 Americas Lentiviral Vector (LVV) CDMO Services Market Size by Type (2017-2022)
5.3 Americas Lentiviral Vector (LVV) CDMO Services Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lentiviral Vector (LVV) CDMO Services Market Size by Region (2017-2022)
6.2 APAC Lentiviral Vector (LVV) CDMO Services Market Size by Type (2017-2022)
6.3 APAC Lentiviral Vector (LVV) CDMO Services Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lentiviral Vector (LVV) CDMO Services by Country (2017-2022)
7.2 Europe Lentiviral Vector (LVV) CDMO Services Market Size by Type (2017-2022)
7.3 Europe Lentiviral Vector (LVV) CDMO Services Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lentiviral Vector (LVV) CDMO Services by Region (2017-2022)
8.2 Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size by Type (2017-2022)
8.3 Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Lentiviral Vector (LVV) CDMO Services Market Forecast
10.1 Global Lentiviral Vector (LVV) CDMO Services Forecast by Regions (2023-2028)
10.1.1 Global Lentiviral Vector (LVV) CDMO Services Forecast by Regions (2023-2028)
10.1.2 Americas Lentiviral Vector (LVV) CDMO Services Forecast
10.1.3 APAC Lentiviral Vector (LVV) CDMO Services Forecast
10.1.4 Europe Lentiviral Vector (LVV) CDMO Services Forecast
10.1.5 Middle East & Africa Lentiviral Vector (LVV) CDMO Services Forecast
10.2 Americas Lentiviral Vector (LVV) CDMO Services Forecast by Country (2023-2028)
10.2.1 United States Lentiviral Vector (LVV) CDMO Services Market Forecast
10.2.2 Canada Lentiviral Vector (LVV) CDMO Services Market Forecast
10.2.3 Mexico Lentiviral Vector (LVV) CDMO Services Market Forecast
10.2.4 Brazil Lentiviral Vector (LVV) CDMO Services Market Forecast
10.3 APAC Lentiviral Vector (LVV) CDMO Services Forecast by Region (2023-2028)
10.3.1 China Lentiviral Vector (LVV) CDMO Services Market Forecast
10.3.2 Japan Lentiviral Vector (LVV) CDMO Services Market Forecast
10.3.3 Korea Lentiviral Vector (LVV) CDMO Services Market Forecast
10.3.4 Southeast Asia Lentiviral Vector (LVV) CDMO Services Market Forecast
10.3.5 India Lentiviral Vector (LVV) CDMO Services Market Forecast
10.3.6 Australia Lentiviral Vector (LVV) CDMO Services Market Forecast
10.4 Europe Lentiviral Vector (LVV) CDMO Services Forecast by Country (2023-2028)
10.4.1 Germany Lentiviral Vector (LVV) CDMO Services Market Forecast
10.4.2 France Lentiviral Vector (LVV) CDMO Services Market Forecast
10.4.3 UK Lentiviral Vector (LVV) CDMO Services Market Forecast
10.4.4 Italy Lentiviral Vector (LVV) CDMO Services Market Forecast
10.4.5 Russia Lentiviral Vector (LVV) CDMO Services Market Forecast
10.5 Middle East & Africa Lentiviral Vector (LVV) CDMO Services Forecast by Region (2023-2028)
10.5.1 Egypt Lentiviral Vector (LVV) CDMO Services Market Forecast
10.5.2 South Africa Lentiviral Vector (LVV) CDMO Services Market Forecast
10.5.3 Israel Lentiviral Vector (LVV) CDMO Services Market Forecast
10.5.4 Turkey Lentiviral Vector (LVV) CDMO Services Market Forecast
10.5.5 GCC Countries Lentiviral Vector (LVV) CDMO Services Market Forecast
10.6 Global Lentiviral Vector (LVV) CDMO Services Forecast by Type (2023-2028)
10.7 Global Lentiviral Vector (LVV) CDMO Services Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Lentiviral Vector (LVV) CDMO Services Product Offered
11.1.3 Thermo Fisher Scientific Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 GenScript ProBio
11.2.1 GenScript ProBio Company Information
11.2.2 GenScript ProBio Lentiviral Vector (LVV) CDMO Services Product Offered
11.2.3 GenScript ProBio Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 GenScript ProBio Main Business Overview
11.2.5 GenScript ProBio Latest Developments
11.3 Hillgene
11.3.1 Hillgene Company Information
11.3.2 Hillgene Lentiviral Vector (LVV) CDMO Services Product Offered
11.3.3 Hillgene Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Hillgene Main Business Overview
11.3.5 Hillgene Latest Developments
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Information
11.4.2 Charles River Laboratories Lentiviral Vector (LVV) CDMO Services Product Offered
11.4.3 Charles River Laboratories Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Charles River Laboratories Main Business Overview
11.4.5 Charles River Laboratories Latest Developments
11.5 Ubrigene
11.5.1 Ubrigene Company Information
11.5.2 Ubrigene Lentiviral Vector (LVV) CDMO Services Product Offered
11.5.3 Ubrigene Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Ubrigene Main Business Overview
11.5.5 Ubrigene Latest Developments
11.6 Obio Technology (shanghai)
11.6.1 Obio Technology (shanghai) Company Information
11.6.2 Obio Technology (shanghai) Lentiviral Vector (LVV) CDMO Services Product Offered
11.6.3 Obio Technology (shanghai) Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Obio Technology (shanghai) Main Business Overview
11.6.5 Obio Technology (shanghai) Latest Developments
11.7 Genesail Biotech (Shanghai)
11.7.1 Genesail Biotech (Shanghai) Company Information
11.7.2 Genesail Biotech (Shanghai) Lentiviral Vector (LVV) CDMO Services Product Offered
11.7.3 Genesail Biotech (Shanghai) Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Genesail Biotech (Shanghai) Main Business Overview
11.7.5 Genesail Biotech (Shanghai) Latest Developments
11.8 Wuxi Apptec
11.8.1 Wuxi Apptec Company Information
11.8.2 Wuxi Apptec Lentiviral Vector (LVV) CDMO Services Product Offered
11.8.3 Wuxi Apptec Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Wuxi Apptec Main Business Overview
11.8.5 Wuxi Apptec Latest Developments
11.9 Porton Advanced Solutions
11.9.1 Porton Advanced Solutions Company Information
11.9.2 Porton Advanced Solutions Lentiviral Vector (LVV) CDMO Services Product Offered
11.9.3 Porton Advanced Solutions Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Porton Advanced Solutions Main Business Overview
11.9.5 Porton Advanced Solutions Latest Developments
11.10 Pharmaron
11.10.1 Pharmaron Company Information
11.10.2 Pharmaron Lentiviral Vector (LVV) CDMO Services Product Offered
11.10.3 Pharmaron Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Pharmaron Main Business Overview
11.10.5 Pharmaron Latest Developments
11.11 Asymchem Laboratories (Tianjin)
11.11.1 Asymchem Laboratories (Tianjin) Company Information
11.11.2 Asymchem Laboratories (Tianjin) Lentiviral Vector (LVV) CDMO Services Product Offered
11.11.3 Asymchem Laboratories (Tianjin) Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Asymchem Laboratories (Tianjin) Main Business Overview
11.11.5 Asymchem Laboratories (Tianjin) Latest Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck Lentiviral Vector (LVV) CDMO Services Product Offered
11.12.3 Merck Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Merck Main Business Overview
11.12.5 Merck Latest Developments
11.13 VectorBuilder
11.13.1 VectorBuilder Company Information
11.13.2 VectorBuilder Lentiviral Vector (LVV) CDMO Services Product Offered
11.13.3 VectorBuilder Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 VectorBuilder Main Business Overview
11.13.5 VectorBuilder Latest Developments
11.14 Yposkesi
11.14.1 Yposkesi Company Information
11.14.2 Yposkesi Lentiviral Vector (LVV) CDMO Services Product Offered
11.14.3 Yposkesi Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Yposkesi Main Business Overview
11.14.5 Yposkesi Latest Developments
11.15 Flash Therapeutics
11.15.1 Flash Therapeutics Company Information
11.15.2 Flash Therapeutics Lentiviral Vector (LVV) CDMO Services Product Offered
11.15.3 Flash Therapeutics Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Flash Therapeutics Main Business Overview
11.15.5 Flash Therapeutics Latest Developments
11.16 VIVEBiotech
11.16.1 VIVEBiotech Company Information
11.16.2 VIVEBiotech Lentiviral Vector (LVV) CDMO Services Product Offered
11.16.3 VIVEBiotech Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 VIVEBiotech Main Business Overview
11.16.5 VIVEBiotech Latest Developments
11.17 Miltenyi Bioindustry
11.17.1 Miltenyi Bioindustry Company Information
11.17.2 Miltenyi Bioindustry Lentiviral Vector (LVV) CDMO Services Product Offered
11.17.3 Miltenyi Bioindustry Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Miltenyi Bioindustry Main Business Overview
11.17.5 Miltenyi Bioindustry Latest Developments
11.18 Genezen
11.18.1 Genezen Company Information
11.18.2 Genezen Lentiviral Vector (LVV) CDMO Services Product Offered
11.18.3 Genezen Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Genezen Main Business Overview
11.18.5 Genezen Latest Developments
11.19 Miltenyi Biotec
11.19.1 Miltenyi Biotec Company Information
11.19.2 Miltenyi Biotec Lentiviral Vector (LVV) CDMO Services Product Offered
11.19.3 Miltenyi Biotec Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Miltenyi Biotec Main Business Overview
11.19.5 Miltenyi Biotec Latest Developments
11.20 Exthera
11.20.1 Exthera Company Information
11.20.2 Exthera Lentiviral Vector (LVV) CDMO Services Product Offered
11.20.3 Exthera Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Exthera Main Business Overview
11.20.5 Exthera Latest Developments
11.21 Catalent
11.21.1 Catalent Company Information
11.21.2 Catalent Lentiviral Vector (LVV) CDMO Services Product Offered
11.21.3 Catalent Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Catalent Main Business Overview
11.21.5 Catalent Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Lentiviral Vector (LVV) CDMO Services Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of IIT Grade
Table 3. Major Players of IND Grade
Table 4. Major Players of Clinical Trial Grade
Table 5. Major Players of Commercial Production Grade
Table 6. Lentiviral Vector (LVV) CDMO Services Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Lentiviral Vector (LVV) CDMO Services Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Type (2017-2022)
Table 9. Lentiviral Vector (LVV) CDMO Services Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Lentiviral Vector (LVV) CDMO Services Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Application (2017-2022)
Table 12. Global Lentiviral Vector (LVV) CDMO Services Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Lentiviral Vector (LVV) CDMO Services Revenue Market Share by Player (2020-2022)
Table 14. Lentiviral Vector (LVV) CDMO Services Key Players Head office and Products Offered
Table 15. Lentiviral Vector (LVV) CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Lentiviral Vector (LVV) CDMO Services Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Regions (2017-2022)
Table 20. Americas Lentiviral Vector (LVV) CDMO Services Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Country (2017-2022)
Table 22. Americas Lentiviral Vector (LVV) CDMO Services Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Type (2017-2022)
Table 24. Americas Lentiviral Vector (LVV) CDMO Services Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Application (2017-2022)
Table 26. APAC Lentiviral Vector (LVV) CDMO Services Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Region (2017-2022)
Table 28. APAC Lentiviral Vector (LVV) CDMO Services Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Type (2017-2022)
Table 30. APAC Lentiviral Vector (LVV) CDMO Services Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Application (2017-2022)
Table 32. Europe Lentiviral Vector (LVV) CDMO Services Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Country (2017-2022)
Table 34. Europe Lentiviral Vector (LVV) CDMO Services Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Type (2017-2022)
Table 36. Europe Lentiviral Vector (LVV) CDMO Services Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Lentiviral Vector (LVV) CDMO Services
Table 45. Key Market Challenges & Risks of Lentiviral Vector (LVV) CDMO Services
Table 46. Key Industry Trends of Lentiviral Vector (LVV) CDMO Services
Table 47. Global Lentiviral Vector (LVV) CDMO Services Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Lentiviral Vector (LVV) CDMO Services Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Lentiviral Vector (LVV) CDMO Services Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Lentiviral Vector (LVV) CDMO Services Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Lentiviral Vector (LVV) CDMO Services Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Lentiviral Vector (LVV) CDMO Services Market Size Market Share Forecast by Application (2023-2028)
Table 53. Thermo Fisher Scientific Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 54. Thermo Fisher Scientific Lentiviral Vector (LVV) CDMO Services Product Offered
Table 55. Thermo Fisher Scientific Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Thermo Fisher Scientific Main Business
Table 57. Thermo Fisher Scientific Latest Developments
Table 58. GenScript ProBio Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 59. GenScript ProBio Lentiviral Vector (LVV) CDMO Services Product Offered
Table 60. GenScript ProBio Main Business
Table 61. GenScript ProBio Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. GenScript ProBio Latest Developments
Table 63. Hillgene Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 64. Hillgene Lentiviral Vector (LVV) CDMO Services Product Offered
Table 65. Hillgene Main Business
Table 66. Hillgene Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Hillgene Latest Developments
Table 68. Charles River Laboratories Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 69. Charles River Laboratories Lentiviral Vector (LVV) CDMO Services Product Offered
Table 70. Charles River Laboratories Main Business
Table 71. Charles River Laboratories Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Charles River Laboratories Latest Developments
Table 73. Ubrigene Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 74. Ubrigene Lentiviral Vector (LVV) CDMO Services Product Offered
Table 75. Ubrigene Main Business
Table 76. Ubrigene Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Ubrigene Latest Developments
Table 78. Obio Technology (shanghai) Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 79. Obio Technology (shanghai) Lentiviral Vector (LVV) CDMO Services Product Offered
Table 80. Obio Technology (shanghai) Main Business
Table 81. Obio Technology (shanghai) Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Obio Technology (shanghai) Latest Developments
Table 83. Genesail Biotech (Shanghai) Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 84. Genesail Biotech (Shanghai) Lentiviral Vector (LVV) CDMO Services Product Offered
Table 85. Genesail Biotech (Shanghai) Main Business
Table 86. Genesail Biotech (Shanghai) Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Genesail Biotech (Shanghai) Latest Developments
Table 88. Wuxi Apptec Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 89. Wuxi Apptec Lentiviral Vector (LVV) CDMO Services Product Offered
Table 90. Wuxi Apptec Main Business
Table 91. Wuxi Apptec Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Wuxi Apptec Latest Developments
Table 93. Porton Advanced Solutions Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 94. Porton Advanced Solutions Lentiviral Vector (LVV) CDMO Services Product Offered
Table 95. Porton Advanced Solutions Main Business
Table 96. Porton Advanced Solutions Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Porton Advanced Solutions Latest Developments
Table 98. Pharmaron Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 99. Pharmaron Lentiviral Vector (LVV) CDMO Services Product Offered
Table 100. Pharmaron Main Business
Table 101. Pharmaron Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Pharmaron Latest Developments
Table 103. Asymchem Laboratories (Tianjin) Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 104. Asymchem Laboratories (Tianjin) Lentiviral Vector (LVV) CDMO Services Product Offered
Table 105. Asymchem Laboratories (Tianjin) Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. Asymchem Laboratories (Tianjin) Main Business
Table 107. Asymchem Laboratories (Tianjin) Latest Developments
Table 108. Merck Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 109. Merck Lentiviral Vector (LVV) CDMO Services Product Offered
Table 110. Merck Main Business
Table 111. Merck Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Merck Latest Developments
Table 113. VectorBuilder Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 114. VectorBuilder Lentiviral Vector (LVV) CDMO Services Product Offered
Table 115. VectorBuilder Main Business
Table 116. VectorBuilder Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 117. VectorBuilder Latest Developments
Table 118. Yposkesi Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 119. Yposkesi Lentiviral Vector (LVV) CDMO Services Product Offered
Table 120. Yposkesi Main Business
Table 121. Yposkesi Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 122. Yposkesi Latest Developments
Table 123. Flash Therapeutics Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 124. Flash Therapeutics Lentiviral Vector (LVV) CDMO Services Product Offered
Table 125. Flash Therapeutics Main Business
Table 126. Flash Therapeutics Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 127. Flash Therapeutics Latest Developments
Table 128. VIVEBiotech Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 129. VIVEBiotech Lentiviral Vector (LVV) CDMO Services Product Offered
Table 130. VIVEBiotech Main Business
Table 131. VIVEBiotech Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 132. VIVEBiotech Latest Developments
Table 133. Miltenyi Bioindustry Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 134. Miltenyi Bioindustry Lentiviral Vector (LVV) CDMO Services Product Offered
Table 135. Miltenyi Bioindustry Main Business
Table 136. Miltenyi Bioindustry Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 137. Miltenyi Bioindustry Latest Developments
Table 138. Genezen Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 139. Genezen Lentiviral Vector (LVV) CDMO Services Product Offered
Table 140. Genezen Main Business
Table 141. Genezen Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 142. Genezen Latest Developments
Table 143. Miltenyi Biotec Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 144. Miltenyi Biotec Lentiviral Vector (LVV) CDMO Services Product Offered
Table 145. Miltenyi Biotec Main Business
Table 146. Miltenyi Biotec Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 147. Miltenyi Biotec Latest Developments
Table 148. Exthera Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 149. Exthera Lentiviral Vector (LVV) CDMO Services Product Offered
Table 150. Exthera Main Business
Table 151. Exthera Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 152. Exthera Latest Developments
Table 153. Catalent Details, Company Type, Lentiviral Vector (LVV) CDMO Services Area Served and Its Competitors
Table 154. Catalent Lentiviral Vector (LVV) CDMO Services Product Offered
Table 155. Catalent Lentiviral Vector (LVV) CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 156. Catalent Main Business
Table 157. Catalent Latest Developments
List of Figures
List of Figures
Figure 1. Lentiviral Vector (LVV) CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lentiviral Vector (LVV) CDMO Services Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Type in 2021
Figure 7. Lentiviral Vector (LVV) CDMO Services in Biopharmaceutical Company
Figure 8. Global Lentiviral Vector (LVV) CDMO Services Market: Biopharmaceutical Company (2017-2022) & ($ Millions)
Figure 9. Lentiviral Vector (LVV) CDMO Services in Academic Scientific Research Institution
Figure 10. Global Lentiviral Vector (LVV) CDMO Services Market: Academic Scientific Research Institution (2017-2022) & ($ Millions)
Figure 11. Global Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Application in 2021
Figure 12. Global Lentiviral Vector (LVV) CDMO Services Revenue Market Share by Player in 2021
Figure 13. Global Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Lentiviral Vector (LVV) CDMO Services Market Size 2017-2022 ($ Millions)
Figure 15. APAC Lentiviral Vector (LVV) CDMO Services Market Size 2017-2022 ($ Millions)
Figure 16. Europe Lentiviral Vector (LVV) CDMO Services Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size 2017-2022 ($ Millions)
Figure 18. Americas Lentiviral Vector (LVV) CDMO Services Value Market Share by Country in 2021
Figure 19. Americas Lentiviral Vector (LVV) CDMO Services Consumption Market Share by Type in 2021
Figure 20. Americas Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Application in 2021
Figure 21. United States Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Region in 2021
Figure 26. APAC Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Application in 2021
Figure 27. China Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Country in 2021
Figure 34. Europe Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Type in 2021
Figure 35. Europe Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Application in 2021
Figure 36. Germany Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Application in 2021
Figure 44. Egypt Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Lentiviral Vector (LVV) CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 50. APAC Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 51. Europe Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 53. United States Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 54. Canada Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 57. China Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 58. Japan Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 59. Korea Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 61. India Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 62. Australia Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 63. Germany Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 64. France Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 65. UK Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 66. Italy Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 67. Russia Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 68. Spain Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 71. Israel Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Lentiviral Vector (LVV) CDMO Services Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets